Skip to main navigation Skip to search Skip to main content

Optimizing treatment strategies in the management of non-small cell lung cancer

  • Gregory A. Otterson

Research output: Contribution to journal › Article › peer-review

Abstract

The management of non-small cell lung cancer (NSCLC) continues to evolve as more genetic mutations and other predictive biologic markers are discovered and targeted therapies are developed. Targeted therapies such as bevacizumab, erlotinib, and crizotinib are only appropriate for select groups of patients. The use of targeted therapies is leading to more individualized therapy.

Original languageEnglish
Pages (from-to)22-24
Number of pages3
JournalJournal of Managed Care Medicine
Volume15
Issue number1
StatePublished - Aug 23 2012

Fingerprint

Dive into the research topics of 'Optimizing treatment strategies in the management of non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this